Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era

Current Opinion in Pediatrics

Volumn 28, Issue 6, 2016, Pages 786-793

  Shaughnessy, Erin E ^a   Stalets, Erika L ^b   Shah, Samir S ^a,c  

^a Division of Regenerative Medicine   (United States)

^b Department of Anesthesia   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Community acquired pneumonia; Diagnostic evaluation; Pneumococcal conjugate vaccine; Pneumonia; Treatment

Indexed keywords

CORTICOSTEROID; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ANTIMICROBIAL THERAPY; BLOOD CELL COUNT; BLOOD CULTURE; CASE MANAGEMENT; CASE STUDY; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; MICROBIOLOGICAL EXAMINATION; OUTPATIENT CARE; PRIORITY JOURNAL; PULSE OXIMETRY; REVIEW; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; VACCINATION; AMBULATORY CARE; BACTERIAL PNEUMONIA; CHILD; COMMUNITY ACQUIRED INFECTION; INFANT; MICROBIOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; STREPTOCOCCUS PNEUMONIA; VIROLOGY; VIRUS PNEUMONIA;

AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFANT; PNEUMOCOCCAL VACCINES; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC;

EID: 84991491240     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000428     Document Type: Review

References (35)

1. Kronman MP, Hersh AL, Feng R, et al. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007. Pediatrics 2011; 127:411-418.
2. Myers AL, Hall M, Williams DJ, et al. Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J 2013; 32:736-740.
3. Beck AF, Florin TA, Campanella S, Shah SS. Geographic variation in hospitalization for lower respiratory tract infections across one county. JAMA Pediatr 2015; 169:846-854.
4. Grant CC, Emery D, Milne T, et al. Risk factors for community-acquired pneumonia in preschool-aged children. J Paediatr Child Health 2012; 48:402-412.
5. Griffin MR, Zhu Y, Moore MR, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155-163.
6. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41.
7. Hampton LM, Farley MM, Schaffner W, et al. Prevention of antibiotic-non-susceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis 2012; 205:401-411.
8. de St Maurice A, Grijalva CG, Fonnesbeck C, et al. Racial and regional differences in rates of invasive pneumococcal disease. Pediatrics 2015; 136:e1186-e1194.
9. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 2006; 118:865-873.
10. Lee GE, Lorch SA, Sheffler-Collins S, et al. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics 2010; 126:204-213.
11. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med 2015; 372:835-845.
12. Williams DJ, Shah SS. Community-acquired pneumonia in the conjugate vaccine era. J Pediatric Infect Dis Soc 2012; 1:314-328.
13. Byington CL, Ampofo K, Stockmann C, et al. Community surveillance of respiratory viruses among families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis 2015; 61:1217-1224.
14. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19:571-582.
15. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701-707.
16. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:e25-e76.
17. Lynch T, Bialy L, Kellner JD, et al. A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS One 2010; 5:e11989.
18. Alario AJ, McCarthy PL, Markowitz R, et al. Usefulness of chest radiographs in children with acute lower respiratory tract disease. J Pediatr 1987; 111:187-193.
19. Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet 1998; 351:404-408.
20. Bushyhead JB, Wood RW, Tompkins RK, et al. The effect of chest radiographs on the management and clinical course of patients with acute cough. Med Care 1983; 21:661-673.
21. Esposito S, Tagliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011; 105:1939-1945.
22. Nascimento-Carvalho CM, Cardoso M-RA, Barral A, et al. Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis 2010; 42:644-649.
23. Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19:598-602.
24. Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001; 17:623-627.
25. Heine D, Cochran C, Moore M, et al. The prevalence of bacteremia in pediatric patients with community-acquired pneumonia: guidelines to reduce the frequency of obtaining blood cultures. Hosp Pediatr 2013; 3:92-96.
26. Iroh Tam PY, Bernstein E, Ma X, Ferrieri P. Blood culture in evaluation of pediatric community-acquired pneumonia: a systematic review and meta-analysis. Hosp Pediatr 2015; 5:324-336.
27. Shah SS, Dugan MH, Bell LM, et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J 2011; 30:475-479.
28. Bonner AB, Monroe KW, Talley LI, et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112:363-367.
29. Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr 2009; 154:91-95.
30. Jefferson T, Jones M, Doshi P, et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014; 348:g2545.
31. AAP Committee On Infectious Diseases. Recommendations for prevention and control of influenza in children, 2016-2017. Pediatrics 2015; 138:.
32. Ambroggio L, Test M, Metlay JP, et al. Comparative effectiveness of betalactam versus macrolide monotherapy in children with pneumonia diagnosed in the outpatient setting. Pediatr Infect Dis J 2015; 34:839-842.
33. Ambroggio L, Test M, Metlay JP, et al. Beta-lactam versus beta-lactam/macrolide therapy in pediatric outpatient pneumonia. Pediatr Pulmonol 2016; 51:541-548.
34. Marti C, Grosgurin O, Harbarth S, et al. Adjunctive corticotherapy for com munity acquired pneumonia: a systematic review and meta-analysis. PLoS One 2015; 10:e0144032.
35. Ambroggio L, Test M, Metlay JP, et al. Adjunct systemic corticosteroid therapy in children with community-acquired pneumonia in the outpatient setting. J Pediatric Infect Dis Soc 2015; 4:21-27.